Defiant, Generic Drug Maker Continues to Raise Prices

No Comments
Despite scrutiny from federal and state investigators, shares of Lannett Company are up 15 percent this year to date.
By GRETCHEN MORGENSON from NYT
Business Day

0 comments

Post a Comment